These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23204245)

  • 21. Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence.
    Zhang Y; Ting RZ; Yang W; Jia W; Li W; Ji L; Guo X; Kong AP; Wing YK; Luk AO; Sartorius N; Morisky DE; Oldenburg B; Weng J; Chan JC;
    J Diabetes; 2015 Nov; 7(6):800-8. PubMed ID: 25349949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of exenatide once weekly in patients with type 2 diabetes mellitus treated with a thiazolidinedione alone or in combination with metformin for 2 years.
    Norwood P; Liutkus JF; Haber H; Pintilei E; Boardman MK; Trautmann ME
    Clin Ther; 2012 Oct; 34(10):2082-90. PubMed ID: 23031623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diabetes mellitus medication choice decision aid: a randomized trial.
    Mullan RJ; Montori VM; Shah ND; Christianson TJ; Bryant SC; Guyatt GH; Perestelo-Perez LI; Stroebel RJ; Yawn BP; Yapuncich V; Breslin MA; Pencille L; Smith SA
    Arch Intern Med; 2009 Sep; 169(17):1560-8. PubMed ID: 19786674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.
    Lewin A; Lipetz R; Wu J; Schwartz S
    Clin Ther; 2007 May; 29(5):844-855. PubMed ID: 17697903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
    Kuenen JC; Borg R; Kuik DJ; Zheng H; Schoenfeld D; Diamant M; Nathan DM; Heine RJ;
    Diabetes Care; 2011 Aug; 34(8):1843-7. PubMed ID: 21700921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
    Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
    Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
    Harris MI;
    Diabetes Care; 2001 Jun; 24(6):979-82. PubMed ID: 11375356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Validity of Self-Reported Measures of Adherence to Noninsulin Antidiabetes Medication against Control of Glycated Hemoglobin Levels.
    Zongo A; Guénette L; Moisan J; Grégoire JP
    Can J Diabetes; 2016 Feb; 40(1):58-65. PubMed ID: 26507401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes control with reciprocal peer support versus nurse care management: a randomized trial.
    Heisler M; Vijan S; Makki F; Piette JD
    Ann Intern Med; 2010 Oct; 153(8):507-15. PubMed ID: 20956707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.
    Buse JB; Rubin CJ; Frederich R; Viraswami-Appanna K; Lin KC; Montoro R; Shockey G; Davidson JA
    Clin Ther; 2005 Aug; 27(8):1181-95. PubMed ID: 16199244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is HbA(1c) affected by glycemic instability?
    Derr R; Garrett E; Stacy GA; Saudek CD
    Diabetes Care; 2003 Oct; 26(10):2728-33. PubMed ID: 14514571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention.
    Odegard PS; Goo A; Hummel J; Williams KL; Gray SL
    Ann Pharmacother; 2005 Mar; 39(3):433-40. PubMed ID: 15701763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemoglobin Glycosylation Index is not related with blood glucose.
    Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
    J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity and glycemic control in patients with type 2 diabetes.
    El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
    Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety profile of exenatide once weekly compared with insulin once daily in Japanese patients with type 2 diabetes treated with oral antidiabetes drug(s): results from a 26-week, randomized, open-label, parallel-group, multicenter, noninferiority study.
    Inagaki N; Atsumi Y; Oura T; Saito H; Imaoka T
    Clin Ther; 2012 Sep; 34(9):1892-908.e1. PubMed ID: 22884767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial.
    Weinger K; Beverly EA; Lee Y; Sitnokov L; Ganda OP; Caballero AE
    Arch Intern Med; 2011 Dec; 171(22):1990-9. PubMed ID: 21986346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.